KRAS and pancreatic neoplasm: Consistent with observations in mouse PDAC, quantitative analysis of nuclear CSA revealed that nuclei from human mutant KRAS pancreatic tumor tissue were reduced in size compared with adjacent normal or KRAS WT PDACs (Figure 1E).